Oxford Pharmascience Group (OXP)

 

OXP Share PerformanceMore

52 week high7.8900 20/05/16
52 week low2.3800 15/09/16
52 week change -3.6250 (-58.00%)
4 week volume7,608,883 05/09/16

Media for (OXP)

Presenter: Marcelo Bravo
13/09/2016
Presenter: Marcelo Bravo
22/04/2016

Latest NewsMore

Oxford Pharmascience - Interim results 2016

Interim results for the 6 months to 30 June 2016

RNS Number: 1399J Oxford Pharmascience Group PLC 07 September 2016 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") Interim results for the six months to 30 June 2016 Oxford Pharmascience Group Plc (AIM: OXP) is pleased to announce its unaudited interim results for the six months to 30 June 2016. HIGHLIGHTS Substantive p...

Oxford Pharmascience downgraded by Beaufort

Beaufort Securities has downgraded its recommendation on Oxford Pharmascience (LON:OXP) to 'hold' (from 'speculative...

Broker Forecast - Beaufort Securities issues a broker note on Oxford Pharmascience Group PLC

Beaufort Securities today downgrades its investment rating on Oxford Pharmascience Group PLC (LON:OXP) to hold (fro...

FTSE rises on pharmas, financials as miners ebb

London stocks headed higher on opening with blue-chips guided by a string of pharmas, financials utilities and commerci...

Commercial Update & Directorate Change

RNS Number: 6697E Oxford Pharmascience Group PLC 20 July 2016 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") Commercial Update and Directorate Change Oxford Pharmascience Group plc (AIM: OXP), the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, provides the ...

Result of AGM

RNS Number: 0129C Oxford Pharmascience Group PLC 22 June 2016 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") Result of AGM Oxford Pharmascience Group plc (AIM: OXP), the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, is pleased to announce that at its Annual G...

Shares Magazine Investor Evening Presentation

RNS Number: 8004Y Oxford Pharmascience Group PLC 20 May 2016 Oxford Pharmascience Group plc ("Oxford Pharmascience" or "the Company") Presentation at the Shares Magazine Investor Evening (London) Oxford Pharmascience, t he specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, announces that ...

Fundamental DataMore

EPS-0.28
Dividend yield0 %

Latest discussion posts More

  • hoping for some good news tomorrow

    a JV perhaps
    3-Mar-2016
    one4all
  • progress?

    Yesterdays announcement should mean good times ahead? . does pharmaspecialist have an opinion? not sure how long something like this would take to get to market but seeing as ...
    6-Nov-2015
    futurewindow
  • Unimpressed

    I am amazed at the lack of information about the company's formulation technology on the web site as this is critical to the company's success. Unless I have missed something, ...
    7-Sep-2015
    pharmaspecialist

Users' HoldingsMore

Users who hold Oxford Pharmascience Group also hold..
GLAXOSMITHKLINE15%
OXFORD BIOMED.15%
MONITISE15%
LLOYDS GRP.15%
XCITE ENERGY15%

Codes & Symbols

ISINGB00B3LXPB43
SymbolsOXP, LSE:OXP, OXP.L, OXP:LN, LON:OXP, XLON:OXP